hemorrhagic colitis - Nursing Case Study
Pathophysiology
• Primary mechanism: Hemorrhagic colitis is primarily caused by infection with Shiga toxin-producing Escherichia coli (STEC), which release potent Shiga toxins that damage the intestinal epithelium, leading to bloody diarrhea.
• Secondary mechanism: The Shiga toxins also trigger inflammatory responses and disrupt endothelial cells in the intestinal blood vessels, causing microvascular injury and further contributing to intestinal bleeding and inflammation.
• Key complication: If untreated, the condition can progress to hemolytic uremic syndrome (HUS), characterized by hemolytic anemia, acute renal failure, and thrombocytopenia, due to the systemic effects of the toxins on the kidneys and blood cells.
Patient Profile
Demographics:
42-year-old female, school teacher
History:
• Key past medical history: Hypertension, Irritable Bowel Syndrome
• Current medications: Lisinopril 10 mg daily, Omeprazole 20 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe abdominal pain and bloody diarrhea
• Key symptoms: Abdominal cramping, nausea, fatigue, decreased urine output
• Vital signs: Temperature 101.3°F (38.5°C), Heart rate 110 bpm, Blood pressure 98/60 mmHg, Respiratory rate 22 breaths per minute, Oxygen saturation 95% on room air
Section 1
As the healthcare team continues to monitor the 42-year-old female patient with hemorrhagic colitis, new diagnostic results reveal significant changes in her laboratory values, indicating the progression towards hemolytic uremic syndrome (HUS). Her complete blood count (CBC) shows a declining hemoglobin level at 9.0 g/dL and a marked decrease in platelet count to 75,000/mm³, suggesting the onset of hemolytic anemia and thrombocytopenia. Additionally, her blood urea nitrogen (BUN) and creatinine levels have increased to 35 mg/dL and 2.0 mg/dL, respectively, highlighting impaired renal function. These lab results align with the feared complications of HUS, requiring immediate clinical intervention to prevent further deterioration.
The patient's clinical status is further compounded by worsening symptoms. She reports increased fatigue and abdominal pain, with her urine output continuing to decrease despite hydration efforts. On reassessment, her vital signs reveal a persistent tachycardia with a heart rate of 115 bpm and hypotension at 95/58 mmHg. Her respiratory rate has increased to 24 breaths per minute, and she appears increasingly lethargic. These findings raise concerns about her fluid balance and hemodynamic stability, indicating a need for escalated care and potential transfer to a higher level of monitoring.
In light of these developments, the healthcare team is prompted to discuss the initiation of specific treatments aimed at managing HUS, including supportive care with intravenous fluids and careful monitoring of renal function. The consideration of renal replacement therapy becomes imperative if her kidney function continues to decline. This scenario necessitates a multidisciplinary approach, involving nephrology and potentially hematology, to address the complex interplay of symptoms and laboratory abnormalities. The case underscores the importance of timely interventions and the careful balancing of treatments to mitigate the risk of further complications.
Section 2
As the healthcare team proceeds with the management of the patient's condition, they notice a significant change in her status. Despite initial interventions, including aggressive intravenous fluid resuscitation, her urine output remains minimal, and her renal function continues to deteriorate. Her latest laboratory results show a further increase in BUN to 45 mg/dL and creatinine to 3.0 mg/dL, indicating worsening kidney impairment. Concurrently, her CBC reveals a further drop in hemoglobin to 8.5 g/dL and platelets to 60,000/mm³, exacerbating concerns about ongoing hemolytic anemia and thrombocytopenia. These changes suggest that the supportive measures may not be sufficient, prompting the team to consider more aggressive interventions.
Clinically, the patient exhibits escalating signs of distress. Her lethargy has progressed to confusion, and she struggles to stay awake during brief interactions. Her vital signs remain concerning, with persistent tachycardia at 120 bpm and hypotension at 90/55 mmHg. The increased respiratory rate of 26 breaths per minute reflects her body's attempt to compensate for potential metabolic acidosis. These findings suggest that she is at risk for progressing to multi-organ dysfunction, emphasizing the urgent need for reevaluation of her management plan.
Given the deterioration, the team holds a multidisciplinary meeting to discuss the initiation of renal replacement therapy, such as continuous renal replacement therapy (CRRT), to address the acute kidney injury and prevent further complications. They also consider consulting hematology for potential plasma exchange therapy, especially given the rapid decline in hematologic parameters. This situation requires careful coordination among the care team to tailor interventions that address the patient's complex needs, with the goal of stabilizing her condition and preventing further systemic compromise. The healthcare team prepares to transfer her to the intensive care unit for closer monitoring and advanced support, recognizing the critical nature of her evolving condition.
Section 3
As the patient is transferred to the intensive care unit, her condition continues to evolve, presenting new challenges for the healthcare team. Shortly after the transfer, the team receives the latest diagnostic results, revealing further perturbations in her clinical state. A repeat arterial blood gas analysis indicates a worsening metabolic acidosis, with a pH of 7.28 and bicarbonate level of 18 mmol/L, confirming the severity of her acid-base imbalance. The lactate level has risen to 4.5 mmol/L, suggesting inadequate tissue perfusion and possible early signs of lactic acidosis, further complicating her condition.
The renal panel shows persistent hyperkalemia with a potassium level of 5.8 mmol/L, raising immediate concerns about cardiac stability. An electrocardiogram (ECG) is quickly performed, revealing peaked T waves, which corroborates the hyperkalemic state and necessitates urgent intervention to prevent arrhythmias. The team promptly administers calcium gluconate as a cardiac membrane stabilizer, along with insulin and dextrose to facilitate intracellular potassium shift, while preparing to initiate CRRT to address the underlying renal failure and electrolyte imbalances.
Despite these efforts, the patient exhibits signs of new complications. Her neurological status deteriorates further, with increased confusion and a lack of response to verbal stimuli. This change raises suspicion of an evolving encephalopathy, possibly related to uremic toxins, hypoperfusion, or metabolic derangements. The team discusses the possibility of initiating plasma exchange therapy as advised by the hematology consult, aiming to address potential thrombotic microangiopathy and mitigate neurological compromise. These developments underscore the complexity of her clinical picture, requiring a refined and dynamic approach to her care plan, as the team navigates the delicate balance of managing her acute multi-system challenges.
Section 4
As the team continues to monitor the patient closely, there is a notable change in her vital signs, indicating a shift in her hemodynamic status. Her blood pressure has dropped to 85/50 mmHg, and her heart rate has increased to 115 beats per minute, suggesting the onset of distributive shock, possibly related to septic or toxic causes. The low urine output, now less than 20 mL/hour, further confirms the declining renal function and systemic perfusion. The nursing team promptly initiates fluid resuscitation with isotonic saline to support her blood pressure while preparing for the potential need for vasopressor therapy to maintain adequate perfusion.
In addition to the hemodynamic changes, the patient's respiratory status is also deteriorating. Her respiratory rate has increased to 28 breaths per minute, and her oxygen saturation has decreased to 90% on 2L nasal cannula, indicating increasing respiratory distress. A repeat chest X-ray reveals bilateral pulmonary infiltrates, raising concerns for acute respiratory distress syndrome (ARDS) as a consequence of systemic inflammation or infection. The team escalates to high-flow nasal cannula oxygen therapy, aiming to improve oxygenation while carefully monitoring for the need for further respiratory support.
These developments highlight the complexity of her condition, requiring ongoing reassessment and adaptation of the treatment plan. The healthcare team remains vigilant, balancing fluid management to optimize cardiac output without exacerbating respiratory compromise. They also deliberate the potential benefits and timing of initiating mechanical ventilation if her respiratory status continues to decline. This scenario underscores the importance of comprehensive and coordinated care, as the team works to stabilize her multi-system involvement while investigating the underlying etiology driving these acute changes.
Section 5
As the healthcare team continues to manage the patient's complex condition, they receive new diagnostic results that offer further insights into her deteriorating status. Blood cultures return positive for Escherichia coli, a common pathogen associated with hemorrhagic colitis, confirming the suspicion of a systemic bacterial infection contributing to her septic shock. Additionally, her complete blood count reveals a significant leukocytosis with a white blood cell count of 18,000/mm³, indicating an ongoing inflammatory response. Her lactate level is elevated at 4.5 mmol/L, underscoring the severity of her tissue hypoperfusion and the need for aggressive management of her shock state.
Concurrent laboratory results show a marked decline in renal function, with her creatinine level now elevated to 2.3 mg/dL, reflecting acute kidney injury likely secondary to hypoperfusion and the systemic inflammatory response. The liver function tests reveal mild elevations in AST and ALT, suggestive of possible hepatic involvement or injury, which may further complicate her clinical picture if not addressed promptly. Meanwhile, her arterial blood gas analysis demonstrates a metabolic acidosis with a pH of 7.28, bicarbonate level of 18 mEq/L, and partial compensation by respiratory alkalosis, as evidenced by a decreased pCO2 of 28 mmHg, indicating the body's attempt to manage the acid-base imbalance.
In response to these findings, the team initiates broad-spectrum antibiotics tailored to cover gram-negative bacteria, with a specific focus on E. coli. They also adjust her fluid resuscitation strategy to mitigate the risk of fluid overload, given her pulmonary status, while starting low-dose norepinephrine to support her blood pressure and improve organ perfusion. The team remains vigilant, closely monitoring her response to these interventions, with particular attention to her renal and respiratory functions. As her condition evolves, they prepare for possible escalation of care, including renal replacement therapy or mechanical ventilation, should her multi-organ involvement continue to progress. This period of critical management emphasizes the need for precise clinical reasoning and timely interventions to navigate her complex and dynamic clinical course.